Piracetam for Treatment of Cocaine Addiction, Phase II - 4

University of Pennsylvania

Status and phase: Withdrawn; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: Piracetam

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000199

K02-00238-4

NIDA-00238-4

K20DA000238 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to follow patients in Phase I of an inpatient study in an eight week open label assessment of piracetam in an outpatient treatment program.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.